The most recent trading session ended with Moderna (MRNA) standing at $34.71, reflecting a +0.26% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.64%.

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...

Federal support for mRNA vaccine research appears in jeopardy after KFF Health News reported Sunday that officials at the ...

Citigroup assumed coverage on shares of Moderna (NASDAQ:MRNA – Free Report) in a research report report published on Thursday ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

The work on mRNA vaccines is especially important for bird flu. Most flu vaccines are currently made using a decades-old ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

NPR reports on the National Institutes of Health funding cuts with insight from two NIH staffers and one person familiar with NIH's activities who requested anonymity because they were not authorized ...

Citi initiated coverage of Moderna (MRNA) with a Neutral rating and $40 price target Healthcare policy remains a key biopharma sector ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...